A kind of preparation method of cariprazine
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGYU JINGXIN PHARMA
- Publication Date
- 2021-10-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to medicinal chemistry, in particular to a preparation method of cariprazine. Background technique
[0002] The structural formula of Cariprazine is shown as the compound of formula A. It was jointly developed by Gedeon Richter Ltd and Forest Laboratories. It was first reported that it has a dopamine D3 / D2 partial agonist, and it has both preferential binding to D3R and DA partial agonists. It is used for the treatment of schizophrenia, mania, and severe depression. Its hydrochloride was listed in the United States as an anti-schizophrenia drug in 2015. The chemical name is trans-1-{4-[2-[ 4-(2,3-Dichlorophenyl)-piperazin-1-yl]ethyl]cyclohexyl}-3,3-dimethylurea hydrochloride.
[0003]
[0004] There are documents to disclose the cariprazine synthesis process route as follows:
[0005]
[0006] As can be seen from the above synthetic route, in the process of synthesizing cariprazine, the classic synthesis process has the fo...